Head and Neck Cancer

Evolutionary Role of Chemotherapy in Advanced Nasopharyngeal Carcinoma: A Literature-based Network Meta-analysis

Evolutionary Role of Chemotherapy in Advanced Nasopharyngeal Carcinoma: A Literature-based Network Meta-analysis

[Cancer Management and Research] This network meta-analysis seeks to establish the optimal treatment in advanced nasopharyngeal carcinoma (NPC).

Mindfulness-based Stress Reduction in Patients With Differentiated Thyroid Cancer Receiving Radioactive Iodine Therapy: A Randomized Controlled Trial

Mindfulness-based Stress Reduction in Patients With Differentiated Thyroid Cancer Receiving Radioactive Iodine Therapy: A Randomized Controlled Trial

[Cancer Management and Research] This research examines the efficacy of mindfulness-based stress reduction (MBSR) on health-related quality of life, depression, and anxiety in patients with differentiated thyroid cancer receiving radioactive iodine therapy.

Toxicity Similar, But Overall Survival Poor in Cetuximab vs Cisplatin for HPV-Positive Oropharyngeal Cancer

Toxicity Similar, But Overall Survival Poor in Cetuximab vs Cisplatin for HPV-Positive Oropharyngeal Cancer

By

In a randomized phase 3 trial, researchers sought to determine if cetuximab-based chemoradiotherapy could be a less-toxic alternative to cisplatin-based chemoradiotherapy in patients with HPV-positive oropharyngeal cancer.

Adjuvant Radiation Therapy Improved Outcomes for Some With Advanced Head and Neck CSCC

Adjuvant Radiation Therapy Improved Outcomes for Some With Advanced Head and Neck CSCC

By

Researchers determined the 5-year overall and disease-free survival for patients with CSCC of the head and neck who received adjuvant radiation therapy.

HNC Survivors Continue to Experience Chronic Systemic Symptoms at 1 Year or More Posttreatment

HNC Survivors Continue to Experience Chronic Systemic Symptoms at 1 Year or More Posttreatment

By

Researchers assessed self-reports of chronic systemic symptoms experienced by head and neck cancer survivors at least 1 year posttreatment.

Head and Neck Cancer Survivors Have Increased Suicide Risk

Head and Neck Cancer Survivors Have Increased Suicide Risk

Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers.

Affordable Care Act Has Positive Impact on Outcomes Among Those With Head and Neck Cancer

Affordable Care Act Has Positive Impact on Outcomes Among Those With Head and Neck Cancer

By

A prospective study collected data on the impact of the ACA on percent insured and outcomes for patients with HNSCC in the first years of healthcare law.

Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer

Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer

By

Results of a population-based survey, presented at the 2018 ASCO Quality Care Symposium, revealed patients' perceptions regarding choice of treatment of differentiated thyroid cancer (DTC).

SCOOPs Program Improves Patient Experience, Reduces Costs

SCOOPs Program Improves Patient Experience, Reduces Costs

By

Researchers report on the effectiveness results of the Supportive Care of Oncology Patients (SCOOPs) Program were presented at the 2018 ASCO Quality Care Symposium.

Integrating Preoperative Oral Care Into Cancer Treatment Plans

Integrating Preoperative Oral Care Into Cancer Treatment Plans

By

Oral care by a dentist was found to reduce pathogenic bacterial plaque thereby decreasing the risk of postoperative pneumonia, a potentially fatal adverse effect, in patients undergoing surgical procedures for cancer.

Late Lower Cranial Neuropathy Worsens Symptom Burden in Oropharyngeal Cancer Survivors

Late Lower Cranial Neuropathy Worsens Symptom Burden in Oropharyngeal Cancer Survivors

Researchers conducted a cross-sectional study to determine the incidence and effect of late lower cranial neuropathies on survivors of oropharyngeal cancers.

Malnutrition, Decreased QOL Possible After Radiation Therapy for Head and Neck Cancer

Malnutrition, Decreased QOL Possible After Radiation Therapy for Head and Neck Cancer

By

In a retrospective study, researchers used established tools to measure the nutritional status of patients with head and neck cancer before, immediately after, and at 2 follow-up points after radiotherapy.

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

By

The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

By

A review of current options and ongoing trials for managing ARIE, a common esophageal adverse effect caused by radiotherapy to the thoracic region for lung, breast, or head and neck cancers, or lymphoma.

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

By

Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

By

Study results presented at 2018 ASCO Annual Meeting demonstrated effectiveness of ado-trastuzumab emtansine in non-breast non-gastric HER2-amplified cancers.

Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes

Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes

By

A study presented at the 2018 ONS Annual Congress explored whether patients can safely bypass SICU after HNC surgery, transferring directly from PACU to a specialized unit within the SO.

Posttreatment Visual Function, Ocular Symptoms Impact QOL in Head and Neck Cancer

Posttreatment Visual Function, Ocular Symptoms Impact QOL in Head and Neck Cancer

By

A link between visual function, ocular symptoms, and quality of life was found in cross-sectional study of patients who underwent radiotherapy for head and neck cancers, according to a presentation at the 2018 ONS Annual Congress.

Dabrafenib-Trametinib Combination Approved for Mutation-Positive Thyroid Cancer

Dabrafenib-Trametinib Combination Approved for Mutation-Positive Thyroid Cancer

By

FDA grants approval to immunotherapy combination in the treatment of unresectable and metastatic BRAF V600E mutation-positive anaplastic thyroid cancer (ATC).

Long-term Impact of Retinoblastoma Therapy on Vision-Related Quality of Life

Long-term Impact of Retinoblastoma Therapy on Vision-Related Quality of Life

By

Using the NEI-VFQ-25, researchers assessed vision-targeted health-related quality of life for survivors of retinoblastoma.

Incidence, Age at Diagnosis Increasing in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

Incidence, Age at Diagnosis Increasing in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

By

A retrospective study demonstrates an increase in HPV16-positive status among patients with OPSCC and a corresponding increase in age at diagnosis.

Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases

Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases

By

Results of a retrospective review assessing the prevalence of chronic opioid use among patients with oropharynx cancer after surgery was presented at the 2018 American Head & Neck Society Annual Meeting.

HMB/Arg/Gln Does Not Reduce Oral Mucositis Incidence in Head and Neck Cancer

HMB/Arg/Gln Does Not Reduce Oral Mucositis Incidence in Head and Neck Cancer

By

In a phase 2 study, researchers sought to determine the effectiveness of adding HMB/Arg/Gln to cisplatin-based chemoradiotherapy for patients with head and cancers to prevent CRT-induced oral mucositis.

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

By

In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.

Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids

Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids

Researchers compared opioid use between head and neck cancer (HNCA) and lung or colon cancer (LCCA) cohorts.

Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen

Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen

By

Study results show the effect on high-grade toxicity when 5-FU is replaced with docetaxel in the EXTREME regimen in the palliative treatment of patients with metastatic SCCHN.

Preoperative Aspirin Use May Not Increase Risk of Bleeding in Thyroid Surgery

Preoperative Aspirin Use May Not Increase Risk of Bleeding in Thyroid Surgery

By

This study sought to determine if continuing preoperative aspirin therapy would increase the risk of bleeding complications in patients undergoing thyroid surgery.

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

By

Study compared the effect of treatments on quality of life in treatment-naïve patients with HNC vs those who underwent radiotherapy and/or chemotherapy, and compared with cancer-free patients.

Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival

Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival

[Cancer Management and Research] Radiation dose, fractionation strategies, and predictive factors of response to therapy in patients with esophageal carcinoma are reviewed to determine if more intense local therapy would lead to better outcomes and for which patients.

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

By

In this study, researchers sought to determine the effect depressive symptoms during treatment planning had on immediate and long-term outcomes for patients with head and neck cancer.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs